Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Imura

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Kekkaku : [Tuberculosis]|October 1, 1984
[Lung function in chronic tubercle bacilli excreters]Y Imura
Horumon to Rinsho. Clinical Endocrinology|April 1, 1972
[Hormone producing tumors]Y Imura
Nihon Naibunpi Gakkai Zasshi|November 20, 1995
[Future aspects on endocrinology]Y Imura
Nihon Kyobu Shikkan Gakkai Zasshi|January 1, 1983
[The flow-volume curve findings with reference to uneven ventilation]Y Imura, A Ichikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 1, 1974
[Intrarenal localization of prostaglandin]Y Imura, M Kuroda
Ganka. Ophthalmology|April 1, 1971
[Micro-adjustment in strabismus surgery]J Tsutsui, Y Imura
Thrombosis Research|July 1, 1990
The role of thromboxane (TX) A2 in rabbit arterial thrombosis induced by endothelial damageY Imura, Z Terashita, K Nishikawa
Biochemical Pharmacology|May 1, 1985
Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the plateletZ Terashita, Y Imura, K Nishikawa
Journal of Lipid Mediators and Cell Signalling|January 1, 1996
Inhibition of arachidonic acid induced-aggregation of rabbit platelets with CV-4151 (isbogrel), a selective thromboxane A2 (TXA2) synthase inhibitor: modulation of the antiplatelet action and prostanoid metabolism by rat aortic ringsZ Terashita, Y Imura, K Nishikawa
Life Sciences|July 14, 1986
Possible role of platelet activating factor (PAF) in disseminated intravascular coagulation (DIC), evidenced by use of a PAF antagonist, CV-3988Y Imura, Z Terashita, K Nishikawa
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Kekkaku : [Tuberculosis]|October 1, 1984
[Lung function in chronic tubercle bacilli excreters]Y Imura
Horumon to Rinsho. Clinical Endocrinology|April 1, 1972
[Hormone producing tumors]Y Imura
Nihon Naibunpi Gakkai Zasshi|November 20, 1995
[Future aspects on endocrinology]Y Imura
Nihon Kyobu Shikkan Gakkai Zasshi|January 1, 1983
[The flow-volume curve findings with reference to uneven ventilation]Y Imura, A Ichikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 1, 1974
[Intrarenal localization of prostaglandin]Y Imura, M Kuroda
Ganka. Ophthalmology|April 1, 1971
[Micro-adjustment in strabismus surgery]J Tsutsui, Y Imura
Thrombosis Research|July 1, 1990
The role of thromboxane (TX) A2 in rabbit arterial thrombosis induced by endothelial damageY Imura, Z Terashita, K Nishikawa
Biochemical Pharmacology|May 1, 1985
Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the plateletZ Terashita, Y Imura, K Nishikawa
Journal of Lipid Mediators and Cell Signalling|January 1, 1996
Inhibition of arachidonic acid induced-aggregation of rabbit platelets with CV-4151 (isbogrel), a selective thromboxane A2 (TXA2) synthase inhibitor: modulation of the antiplatelet action and prostanoid metabolism by rat aortic ringsZ Terashita, Y Imura, K Nishikawa
Life Sciences|July 14, 1986
Possible role of platelet activating factor (PAF) in disseminated intravascular coagulation (DIC), evidenced by use of a PAF antagonist, CV-3988Y Imura, Z Terashita, K Nishikawa
Pageof 8